Jasper Therapeutics, Inc.

Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.

JSPR | NDAQ

Overview

Corporate Details

ISIN(s):: US4718712023 (+3 more)
LEI:
Country:: United States of America
Address:: 2200 BRIDGE PKWY SUITE #102, 94065 REDWOOD CITY
Website:: https://jaspertx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for mast cell-driven diseases and as a conditioning agent for hematopoietic stem cell transplantation. The company's lead product candidate is briquilimab, a targeted anti-KIT (CD117) monoclonal antibody designed to deplete mast cells. Jasper is evaluating briquilimab in clinical studies for the treatment of chronic immunological and inflammatory diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to develop safer and more effective therapies for patients with serious chronic diseases by harnessing the power of mast cell depletion.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Jasper Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Jasper Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Jasper Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ASKA Pharmaceutical Holdings CO., Ltd. Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.	Japan	4886
Aspire Biopharma Holdings, Inc. Developing a nano-platform for rapid, sublingual delivery of reformulated medications.	United States of America	ASBP
ASSEMBLY BIOSCIENCES, INC. Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.	United States of America	ASMB
Assertio Holdings, Inc. Offers branded prescription drugs for neurology, pain, and CNS to US patients.	United States of America	ASRT
Astellas Pharma Inc. A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.	Japan	4503
Astena Holdings Co., Ltd. Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.	Japan	8095
AstraZeneca PLC Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.	United Kingdom	AZN
ASTRAZENECA PLC Biopharmaceutical firm developing medicines for oncology, rare diseases, and metabolic disorders.	United States of America	AZN
Astria Therapeutics, Inc. Developing long-acting therapies for rare allergic and immunologic diseases like HAE.	United States of America	ATXS
ATAI Life Sciences N.V. Clinical-stage biopharma creating novel psychedelic drugs for mental health disorders.	United States of America	ATAI